9-92474742-C-CTCATCA
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBA1
The ENST00000375544.7(ASPN):c.155_156insTGATGA(p.Asp50_Asp51dup) variant causes a inframe insertion change. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.073 ( 444 hom., cov: 0)
Exomes 𝑓: 0.073 ( 2003 hom. )
Consequence
ASPN
ENST00000375544.7 inframe_insertion
ENST00000375544.7 inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 4.52
Genes affected
ASPN (HGNC:14872): (asporin) This gene encodes a cartilage extracellular protein that is member of the small leucine-rich proteoglycan family. The encoded protein may regulate chondrogenesis by inhibiting transforming growth factor-beta 1-induced gene expression in cartilage. This protein also binds collagen and calcium and may induce collagen mineralization. Polymorphisms in the aspartic acid repeat region of this gene are associated with a susceptibility to osteoarthritis, and also with intervertebral disc disease. Alternative splicing of this gene results in multiple transcript variants.[provided by RefSeq, Jul 2014]
CENPP (HGNC:32933): (centromere protein P) CENPP is a subunit of a CENPH (MIM 605607)-CENPI (MIM 300065)-associated centromeric complex that targets CENPA (MIM 117139) to centromeres and is required for proper kinetochore function and mitotic progression (Okada et al., 2006 [PubMed 16622420]).[supplied by OMIM, Mar 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant 9-92474742-C-CTCATCA is Benign according to our data. Variant chr9-92474742-C-CTCATCA is described in ClinVar as [Benign]. Clinvar id is 1237100.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0781 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ASPN | NM_017680.6 | c.155_156insTGATGA | p.Asp50_Asp51dup | inframe_insertion | 2/8 | ENST00000710274.1 | NP_060150.4 | |
ASPN | NM_001193335.3 | c.155_156insTGATGA | p.Asp50_Asp51dup | inframe_insertion | 2/6 | NP_001180264.1 | ||
CENPP | NM_001012267.3 | c.564+94922_564+94927dup | intron_variant | ENST00000375587.8 | NP_001012267.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ASPN | ENST00000375544.7 | c.155_156insTGATGA | p.Asp50_Asp51dup | inframe_insertion | 2/8 | 1 | ENSP00000364694 | P1 | ||
CENPP | ENST00000375587.8 | c.564+94922_564+94927dup | intron_variant | 1 | NM_001012267.3 | ENSP00000364737 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0727 AC: 10723AN: 147504Hom.: 444 Cov.: 0
GnomAD3 genomes
AF:
AC:
10723
AN:
147504
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0728 AC: 100838AN: 1385086Hom.: 2003 Cov.: 0 AF XY: 0.0713 AC XY: 49141AN XY: 689672
GnomAD4 exome
AF:
AC:
100838
AN:
1385086
Hom.:
Cov.:
0
AF XY:
AC XY:
49141
AN XY:
689672
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0727 AC: 10735AN: 147610Hom.: 444 Cov.: 0 AF XY: 0.0717 AC XY: 5144AN XY: 71758
GnomAD4 genome
AF:
AC:
10735
AN:
147610
Hom.:
Cov.:
0
AF XY:
AC XY:
5144
AN XY:
71758
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 05, 2021 | Reported in 3.1% of alleles of patients with developmental hip dysplasia in the Han Chinese population, but also seen in 3.4% of alleles of control samples, which was not a statistically significant difference (Shi et al., 2011); In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; The D15 allele is described as a possible risk allele associated with knee osteoarthritis in the Greek population however, this finding was not statistically significant (Kaliakatsos et al., 2006); Among Han Chinese patients with ankylosing spondylitis the frequency of the D15 allele was the same as in controls (Liu et al., 2010); In-frame duplication of 2 Aspartate residues, which results in an allele with 15 Aspartate residues, or a D15 allele; This variant is associated with the following publications: (PMID: 21329514, 16377215, 20144272, 29233086) - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at